Aspen Neuroscience develops autologous iPSC-derived cell replacement therapies for patients with Parkinson's disease and other high unmet medical needs. The company's lead candidate, ANPD001, is a first-in-class personalized cell therapy that uses a patient's own cells to regenerate lost dopamine neurons without requiring immunosuppression. Aspen operates a world-class manufacturing facility utilizing automation, machine learning, and robotics to enable scalable, reproducible production of personalized cell therapies. The company is eyeing Phase 3 trials and is positioned for potential commercial launch and IPO in 2026. Signal Plug searches live against aspen-neuro.com's mail server to find and verify email addresses for any Aspen Neuroscience employee.
Signal Plug searches live against aspen-neuro.com's mail server — not a static database. Get a verified email for any Aspen Neuroscience employee with confidence score in under 2 seconds.
94% accuracy · No credit card required · 10 free searches/month
Aspen Neuroscience develops autologous iPSC-derived cell replacement therapies for patients with Parkinson's disease and other high unmet medical needs. The company's lead candidate, ANPD001, is a first-in-class personalized cell therapy that uses a patient's own cells to regenerate lost dopamine neurons without requiring immunosuppression. Aspen operates a world-class manufacturing facility utilizing automation, machine learning, and robotics to enable scalable, reproducible production of personalized cell therapies. The company is eyeing Phase 3 trials and is positioned for potential commercial launch and IPO in 2026.
Competitive Advantage
Aspen's founder, Jeanne Frances Loring, previously founded Arcos BioScience (1999) and holds the prestigious position of founding Director of the Center for Regenerative Medicine at Scripps Research Institute. The company's technology leverages autologous (patient-derived) iPSC cells, eliminating the need for immunosuppression—a major advantage over allogeneic therapies. Aspen's manufacturing strategy emphasizes commercial scalability of personalized medicine through automation and robotics, addressing a critical barrier to cell therapy viability. The company's positioning suggests a potential IPO within the 2026 calendar year, following Phase 3 advancement.
The most commonly verified format at Aspen Neuroscience:
Medium ConfidenceSignal Plug tests all common patterns against Aspen Neuroscience's live mail server and returns whichever passes the SMTP check.
Run a live search for Aspen Neuroscience →Data-driven signals to help you prospect Aspen Neuroscience effectively.
Aspen recruits top scientists, neurobiologists, and clinical development experts from leading research institutions and biotech firms. The company targets experienced pharmaceutical and biotech executives familiar with cell therapy manufacturing, clinical trials, and regenerative medicine commercialization.
Primary Contact
Chief Scientific Officer
Tuesday–Thursday, 9am–11am
Signal Plug performs live SMTP verification against aspen-neuro.com's mail server — not a static scraped database — which means results reflect the real, current state of Aspen Neuroscience's email infrastructure. Here's how to run a lookup:
Create a free account
Sign up at Signal Plug in under 30 seconds. No credit card required. The Free plan includes 10 searches per month so you can test the tool with real Aspen Neuroscience contacts before upgrading.
Enter the contact's name
Type the first and last name of the Aspen Neuroscience employee you want to reach. Signal Plug handles all seniority levels, from C-suite to individual contributors.
Enter the domain
Use aspen-neuro.com. Signal Plug tests all common naming patterns automatically and returns only the format that passes the SMTP check.
Get a verified result
Signal Plug returns an email address with a confidence score (0–100) and deliverability status (Valid, Risky, or Catch-all) within 2 seconds. The confidence score tells you how reliable the result is before you use it.
Export and use
One-click CSV export lets you bring Aspen Neuroscience contacts into Salesforce, HubSpot, Outreach, Lemlist, or any other tool in your stack. Growth and Scale plan users can run bulk lookups across an entire list of Aspen Neuroscience names in a single batch.
Whether you're running outbound sales, recruiting, or building a partnership list, these are the roles most frequently contacted at Biotechnology like Aspen Neuroscience.
Based on Aspen Neuroscience's profile, the highest-value contacts for outbound are:
Signal Plug works for any role at any seniority level at aspen-neuro.com. If you have a name and the domain, you can find a verified email.
How well Aspen Neuroscience fits a typical B2B outbound pipeline, based on available signals.
Good Fit
Funnel Fit Score
Most email finder tools pull from static databases of scraped email addresses. These databases go stale as people change jobs and companies update their email infrastructure. Signal Plug takes a different approach: every search performs a live check against aspen-neuro.com's mail server using SMTP verification. This means results reflect the current state of Aspen Neuroscience's email system — not a cached result from months or years ago.
Signal Plug enriches every result with supporting data: a confidence score (0–100), deliverability status (Valid, Risky, or Catch-all), job title where available, and LinkedIn profile URL. This context helps you prioritize which Aspen Neuroscience contacts to email first and personalize your outreach before you hit send. Plans start at $29/month for 500 searches — no annual contracts or seat fees.
Signal Plug performs a live SMTP check against aspen-neuro.com's mail server for every query — not a static database lookup. Our platform-wide accuracy rate is 94%. Each result comes with a confidence score (0–100) so you can gauge reliability before using the address.
Free plan: 10 searches. Starter ($29/mo): 500. Growth ($149/mo): 2,000. Scale ($299/mo): 5,000. No company-specific caps.
No. Signal Plug generates and verifies emails in real time via SMTP checks — no static database of Aspen Neuroscience employee emails is maintained.
Yes. Growth and Scale plan users can upload a CSV of names and run bulk lookups against aspen-neuro.com in a single batch.
ANPD001 is Aspen's lead candidate, a first-in-class autologous iPSC-derived dopamine neuron replacement therapy for Parkinson's disease designed to regenerate lost dopamine-producing cells.
Unlike existing medicines that cannot reach the affected brain regions, ANPD001 uses a patient's own cells placed directly where needed, regenerating dopamine without requiring immunosuppression.
No, ANPD001 is investigational and not yet approved by the FDA; the company is advancing toward Phase 3 trials.
At this time, Aspen does not offer or participate in compassionate use or expanded access programs for ANPD001.
Signal Plug searches in real time against aspen-neuro.com's mail server to find and verify email addresses for Aspen Neuroscience employees. Enter a name, enter the domain, get a verified result with a confidence score in under 2 seconds.
Start finding emails free →10 free searches · No credit card required · Upgrade from $29/month